Metagenomi Therapeutics (MGX) Selling, General & Administrative (2023 - 2026)
Metagenomi Therapeutics' Selling, General & Administrative was $6 million in Q2 2026, down 14.1% from $6.99 million a year earlier and down 8.1% from the prior quarter.
Powered by 
Analysis
Metagenomi Therapeutics (MGX) Selling, General & Administrative (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Metagenomi Therapeutics' Selling, General & Administrative was $25.53 million through Jun 30, 2026, down 10.5% year-over-year; for FY2025, it was $26.79 million, down 16.3% from FY2024.
- In earlier years, Selling, General & Administrative was $32.02 million in FY2024 (+11.0%) and $28.85 million in FY2023.
- The Q2 2026 figure marks the lowest quarterly Selling, General & Administrative in data going back to Q1 2023.
- Compared with a year earlier, Selling, General & Administrative has declined for eight straight quarters, with an average decline of 11.8% over the last eight quarters.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q1 2024 (growth of 35.4%); the worst was Q1 2025 (a decline of 22.2%).
- Per Business Quant data, MGX's Selling, General & Administrative in the three quarters before Q2 2026 was $6.54 million (Q1 2026), $6.78 million (Q4 2025) and $6.22 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Metagenomi Therapeutics | 30.60 Mn | -575.14 Mn | - | 6.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.00 Mn |
| Mar 31, 2026 | 6.54 Mn |
| Dec 31, 2025 | 6.78 Mn |
| Sep 30, 2025 | 6.22 Mn |
| Jun 30, 2025 | 6.99 Mn |
| Mar 31, 2025 | 6.81 Mn |
| Dec 31, 2024 | 7.07 Mn |
| Sep 30, 2024 | 7.64 Mn |
| Jun 30, 2024 | 8.55 Mn |
| Mar 31, 2024 | 8.75 Mn |
| Dec 31, 2023 | 7.84 Mn |
| Sep 30, 2023 | 7.92 Mn |
| Jun 30, 2023 | 6.62 Mn |
| Mar 31, 2023 | 6.47 Mn |
API Access
Metagenomi Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=MGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "MGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=MGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();